» Articles » PMID: 9986846

Spread of Amikacin Resistance in Acinetobacter Baumannii Strains Isolated in Spain Due to an Epidemic Strain

Overview
Specialty Microbiology
Date 1999 Feb 13
PMID 9986846
Citations 18
Authors
Affiliations
Soon will be listed here.
Abstract

Sixteen amikacin-resistant clinical Acinetobacter baumannii isolates from nine different hospitals in Spain were investigated to determine whether the high incidence of amikacin-resistant A. baumannii was due to the dissemination of an amikacin-resistant strain or to the spread of an amikacin resistance gene. The epidemiological relationship studied by repetitive extragenic palindromic PCR and low-frequency restriction analysis of chromosomal DNA showed that the same clone was isolated in eight of nine hospitals, although other clones were also found. The strains were studied for the presence of the aph(3')-VIa and aac(6')-I genes, which encode enzymes which inactivate amikacin, by PCR. All 16 clinical isolates had positive PCRs with primers specific for the amplification of the aph(3')-VIa gene, whereas none had a positive reaction for the amplification of the aac(6')-I gene. Therefore, the high incidence of amikacin resistance among clinical A. baumannii isolates in Spain was mainly due to an epidemic strain, although the spread of the aph(3')-VI gene cannot be ruled out.

Citing Articles

The Role of Uniform Meropenem Usage in Clone Replacement.

Balazs B, Toth Z, Nagy F, Kovacs R, Toth H, Nagy J Antibiotics (Basel). 2021; 10(2).

PMID: 33572723 PMC: 7911629. DOI: 10.3390/antibiotics10020127.


Amikacin resistance due to the aphA6 gene in multi-antibiotic resistant Acinetobacter baumannii isolates belonging to global clone 1 from Iran.

Aris P, Boroumand M, Douraghi M BMC Microbiol. 2019; 19(1):221.

PMID: 31533627 PMC: 6751817. DOI: 10.1186/s12866-019-1592-6.


Origin in Acinetobacter guillouiae and dissemination of the aminoglycoside-modifying enzyme Aph(3')-VI.

Yoon E, Goussard S, Touchon M, Krizova L, Cerqueira G, Murphy C mBio. 2014; 5(5):e01972-14.

PMID: 25336457 PMC: 4212838. DOI: 10.1128/mBio.01972-14.


Directed evolution of aminoglycoside phosphotransferase (3') type IIIa variants that inactivate amikacin but impose significant fitness costs.

Kramer J, Matsumura I PLoS One. 2013; 8(10):e76687.

PMID: 24204655 PMC: 3800079. DOI: 10.1371/journal.pone.0076687.


DNA microarray for genotyping antibiotic resistance determinants in Acinetobacter baumannii clinical isolates.

Dally S, Lemuth K, Kaase M, Rupp S, Knabbe C, Weile J Antimicrob Agents Chemother. 2013; 57(10):4761-8.

PMID: 23856783 PMC: 3811405. DOI: 10.1128/AAC.00863-13.


References
1.
Buisson Y, Tran Van Nhieu G, Ginot L, Bouvet P, SCHILL H, Driot L . Nosocomial outbreaks due to amikacin-resistant tobramycin-sensitive Acinetobacter species: correlation with amikacin usage. J Hosp Infect. 1990; 15(1):83-93. DOI: 10.1016/0195-6701(90)90024-i. View

2.
Cefai C, Richards J, Gould F, McPeake P . An outbreak of Acinetobacter respiratory tract infection resulting from incomplete disinfection of ventilatory equipment. J Hosp Infect. 1990; 15(2):177-82. DOI: 10.1016/0195-6701(90)90128-b. View

3.
Lambert T, Gerbaud G, Bouvet P, Vieu J, Courvalin P . Dissemination of amikacin resistance gene aphA6 in Acinetobacter spp. Antimicrob Agents Chemother. 1990; 34(6):1244-8. PMC: 171792. DOI: 10.1128/AAC.34.6.1244. View

4.
Vila J, Almela M, Jimenez de Anta M . Laboratory investigation of hospital outbreak caused by two different multiresistant Acinetobacter calcoaceticus subsp. anitratus strains. J Clin Microbiol. 1989; 27(5):1086-9. PMC: 267488. DOI: 10.1128/jcm.27.5.1086-1089.1989. View

5.
Lambert T, Gerbaud G, Courvalin P . Transferable amikacin resistance in Acinetobacter spp. due to a new type of 3'-aminoglycoside phosphotransferase. Antimicrob Agents Chemother. 1988; 32(1):15-9. PMC: 172089. DOI: 10.1128/AAC.32.1.15. View